ArticleJournal of hepatology2017

Corrigendum to "Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension" [J Hepatol 62 (2015) 325-331].

Rajeshwar P Mookerjee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.